Safety and efficacy of apatinib combined with iodine-125 in chemotherapy-refractory advanced lung cancer: A case report

INTRODUCTION: Apatinib is a novel anti-angiogenic agent that targets vascular endothelial growth factor receptor-2, and is effective in patients with advanced lung cancer who are refractory to first-line chemotherapy. However, there are limited reports on concurrent apatinib therapy with iodine-125...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yunchao, Yin, Shiqiang, Jia, Yingjie, Qin, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437787/
https://www.ncbi.nlm.nih.gov/pubmed/32872014
http://dx.doi.org/10.1097/MD.0000000000021600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437787/
https://www.ncbi.nlm.nih.gov/pubmed/32872014
http://dx.doi.org/10.1097/MD.0000000000021600

Ejemplares similares